LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2012
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2012-10-31$0.39/sh+20,885$8,145→ 89,503 total
Footnotes (1)
- [F1]Shares acquired under the Peregrine employee stock purchase plan on October 31, 2012.